HIGHLIGHTS
- who: Wei Liu from the University of California, Los Angeles, United States have published the research work: Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: Au0092Review and Clinical Trial Protocol, in the Journal: (JOURNAL)
SUMMARY
PSMA PET provides better distant staging and can identify extra-prostatic extension, especially among men with higher risk disease. 18F-DCFPyL and 18FPSMA-1007 are the most clinically established 18F-labeled radiotracers for PSMA-targeted PET imaging. The authors have demonstrated through a prospective trial of the preoperative imaging that 18F-DCFPyL-PET/MRI could identify DILs as verified . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.